Venous thromboembolism prophylaxis in gynecologic surgery: a systematic review.
David D Rahn, Mamta M Mamik, Tatiana V D Sanses, Kristen A Matteson, Sarit O Aschkenazi, Blair B Washington, Adam C Steinberg, Heidi S Harvie, James C Lukban, Katrin Uhlig, Ethan M Balk, Vivian W Sung, Society of Gynecologic Surgeons Systematic Review Group
Author Information
David D Rahn: From the University of Texas Southwestern Medical Center, Dallas, Texas; the University of New Mexico Health Sciences Center, Albuquerque, New Mexico; the University Hospitals Case Medical Center, Cleveland, Ohio; Women and Infants Hospital of Rhode Island/Brown Medical School, Providence, Rhode Island; Medical College of Wisconsin, Waukesha, Wisconsin; Hartford Hospital/University of Connecticut School of Medicine, Hartford, Connecticut; the University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania; Eastern Virginia Medical School, Norfolk, Virginia; and Tufts Medical Center, Boston, Massachusetts.
OBJECTIVE: To comprehensively review and critically assess the available gynecologic surgery venous thromboembolism prophylaxis literature and provide clinical practice guidelines. DATA SOURCES: MEDLINE and Cochrane databases from inception to July 2010. We included randomized controlled trials in gynecologic surgery populations. Interventions and comparators included graduated compression stockings, intermittent pneumatic compression, unfractionated heparin, and low molecular weight heparin; placebo and routine postoperative care were allowed as comparators. METHODS OF STUDY SELECTION: One thousand two hundred sixty-six articles were screened, and 14 randomized controlled trials (five benign gynecologic, nine gynecologic oncology) met eligibility criteria. In addition, nine prospective or retrospective studies with at least 150 women were identified and provided data on venous thromboembolism risk stratification, gynecologic laparoscopy, and urogynecologic populations. TABULATION, INTEGRATION, AND RESULTS: Two reviewers independently screened articles with discrepancies adjudicated by a third. Eligible randomized controlled trials were extracted for these characteristics: study, participant, surgery, intervention, comparator, and outcomes data, including venous thromboembolism incidence and bleeding complications. Studies were individually and collectively assessed for methodologic quality and strength of evidence. Overall incidence of clinical venous thromboembolism was 0-2% in the benign gynecologic population. With use of intermittent pneumatic compression for benign major procedures, venous thromboembolism incidence was less than 1%. No venous thromboembolisms were identified in prospective studies of benign laparoscopic procedures. Overall quality of evidence in the benign gynecologic literature was poor. Gynecologic-oncology randomized controlled trials reported venous thromboembolism incidence (including "silent" venous thromboembolisms) of 0-14.8% with prophylaxis and up to 34.6% without prophylaxis. Fair quality of evidence supports that unfractionated heparin and intermittent pneumatic compression are both superior to placebo or no intervention but insufficient to determine whether heparins are superior to intermittent pneumatic compression for venous thromboembolism prevention. Combining two of three risks (aged 60 years or older, cancer, or personal venous thromboembolism history) substantially elevated the risk of venous thromboembolism. CONCLUSION: Intermittent pneumatic compression provides sufficient prophylaxis for the majority of gynecology patients undergoing benign surgery. Additional risk factors warrant the use of combined mechanical and pharmacologic prophylaxis.
References
Heit JA. The epidemiology of venous thromboembolism in the community. Arterioscler Thromb Vasc Biol 2008;28:370–2.
Clarke-Pearson DL, Synan IS, Colemen RE, Hinshaw W, Creasman WT. The natural history of postoperative venous thromboemboli in gynecologic oncology: a prospective study of 382 patients. Am J Obstet Gynecol 1984;148:1051–4.
Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR, et al.. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008;133(suppl):381S–453S.
Jackson E, Curtis KM, Gaffield ME. Risk of venous thromboembolism during the postpartum period: a systematic review. Obstet Gynecol 2011;117:691–703.
Prevention of deep vein thrombosis and pulmonary embolism. ACOG Practice Bulletin No. 84. American College of Obstetricians and Gynecologists. Obstet Gynecol 2007;110:429–40.
Counsell C. Formulating questions and locating primary studies for inclusion in systematic reviews. Ann Intern Med 1997;127:380–7.
Sung VW, Rogers RG, Schaffer JI, Balk EM, Uhlig K, Lau J, et al.. Graft use in transvaginal pelvic organ prolapse repair: a systematic review. Obstet Gynecol 2008;112:1131–42.
Rahn DD, Abed H, Sung VW, Matteson KA, Rogers RG, Morrill MY, et al.. Systematic review highlights difficulty interpreting diverse clinical outcomes in abnormal uterine bleeding trials. J Clin Epidemiol 2011;64:293–300.
Owens DK, Lohr KN, Atkins D, Treadwell JR, Reston JT, Bass EB, et al.. AHRQ series paper 5: grading the strength of a body of evidence when comparing medical interventions—agency for healthcare research and quality and the effective health-care program. J Clin Epidemiol 2010;63:513–23.
Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S, et al.. Grading quality of evidence and strength of recommendations. BMJ 2004;328:1490.
Welti H. Thrombo-embolytic prophylaxis using physiotherapy with and without low doses of heparin in gynecology and obstetrics. Results of a controlled and randomized mult-cancer study [in French]. Rev Med Suisse Romande 1981;101:925–34.
Studer-Schar A. Hemorrhages caused by ‘low dose’ heparin and placebo (NaCl solution) in surgical gynecology [in German]. Gynakol Rundsch 1982;22:241–8.
Docherty PW, Goodman JD, Hill JG, Pickles BG, Boardman J, Taylor CG, et al.. The effect of low-dose heparin on blood loss at abdominal hysterectomy. Br J Obstet Gynaecol 1983;90:759–63.
Borstad E, Urdal K, Handeland G, Abildgaard U. Comparison of low molecular weight heparin compared with unfractionated heparin in gynecological surgery. Acta Obstet Gynecol Scand 1988;67:99–103.
Borstad E, Urdal K, Handeland G, Abildgaard U. Comparison of low molecular weight heparin compared with unfractionated heparin in gynecological surgery. II: Reduced dose of low molecular weight heparin. Acta Obstet Gynecol Scand 1992;71:471–5.
Clarke-Pearson DL, Coleman RE, Synan IS, Hinshaw W, Creasman WT. Venous thromboembolism prophylaxis in gynecologic oncology: a prospective, controlled trial of low-dose heparin. Am J Obstet Gynecol 1983;145:606–13.
Clarke-Pearson DL, DeLong ER, Synan IS, Creasman WT. Complications of low-dose heparin prophylaxis in gynecologic oncology surgery. Obstet Gynecol 1984;64:689–94.
Clark-Pearson DL, DeLong E, Synan IS, Soper JT, Creasman WT, Coleman RE. A controlled trial of two low-dose heparin regimens for the prevention of postoperative deep vein thrombosis. Obstet Gynecol 1990;75:684–9.
Fricker JP, Vergnes Y, Schach R, Heitz A, Eber M, Grunebaum L, et al.. Low dose heparin versus low molecular weight heparin (Kabi 2165, Fragmin) in the prophylaxis of thromboembolic complications of abdominal oncological surgery. Eur J Clin Invest 1988;18:561–7.
Ward B, Pradhan S. Comparison of low molecular weight heparin (Fragmin) with sodium heparin for prophylaxis against postoperative thrombosis in women undergoing major gynaecological surgery. Aust N Z J Obstet Gynaecol 1998;38:91–2.
Baykal C, Al A, Demirtas E, Ayhan A. Comparison of enoxaparin and standard heparin in gynaecologic oncologic surgery: a randomised prospective double-blind clinical study. Eur J Gynaecol Oncol 2001;22:127–30.
Clarke-Pearson DL, Creasman WT, Coleman RE, Synan IS, Hinshaw WM. Perioperative external pneumatic calf compression as thromboembolism prophylaxis in gynecologic oncology: report of a randomized controlled trial. Gynecol Oncol 1984;18:226–32.
Clarke-Pearson DL, Synan IS, Hinshaw WM, Coleman RE, Creasman WT. Prevention of postoperative venous thromboembolism by external pneumatic calf compression in patients with gynecologic malignancy. Obstet Gynecol 1984;63:92–8.
Maxwell GL, Synan I, Dodge R, Carroll B, Clarke-Pearson DL. Pneumatic compression versus low molecular weight heparin in gynecologic oncology surgery: a randomized trial. Obstet Gynecol 2001;98:989–95.
Clarke-Pearson DL, DeLong ER, Synan IS, Coleman RE, Creasman WT. Variables associated with postoperative deep venous thrombosis: a prospective study of 411 gynecology patients and creation of a prognostic model. Obstet Gynecol 1987;69:146–50.
Clarke-Pearson DL, Dodge RK, Synan I, McClelland RC, Maxwell GL. Venous thromboembolism prophylaxis: patients at high risk to fail intermittent pneumatic compression. Obstet Gynecol 2003;101:157–63.
Martino MA, Borges E, Williamson E, Siegfried S, Cantor AB, Lancaster J, et al.. Pulmonary embolism after major abdominal surgery in gynecologic oncology. Obstet Gynecol 2006;107:666–71.
Einstein MH, Kushner DM, Connor JP, Bohl AA, Best TJ, Evans MD, et al.. A protocol of dual prophylaxis for venous thromboembolism prevention in gynecologic cancer patients. Obstet Gynecol 2008;112:1091–7.
Feng L, Song J, Wong F, Xia E. Incidence of deep venous thrombosis after gynaecological laparoscopy. Chin Med J (Engl) 2001;114:632–5.
Ageno W, Manfredi E, Dentali F, Silingardi M, Ghezzi F, Camporese G, et al.. The incidence of venous thromboembolism following gynecologic laparoscopy: a multicenter, prospective cohort study. J Thromb Haemost 2007;5:503–6.
Healey MG, Maher PJ, Hill DJ, Meagher SE, Tregaskis-Lye LE. The risk of venous thrombosis following gynaecological laparoscopic surgery. Med J Aust 1998;168:524.
Solomon ER, Frick AC, Paraiso MF, Barber MD. Risk of deep venous thrombosis and pulmonary embolism in urogynecologic surgical patients. Am J Obstet Gynecol 2010;203:510.e1–4.
Nick AM, Schmeler KM, Frumovitz MM, Soliman PT, Spannuth WA, Burzawa JK, et al.. Risk of thromboembolic disease in patients undergoing laparoscopic gynecologic surgery. Obstet Gynecol 2010;116:956–61.
Santoso JT, Evans L, Lambrecht L, Wan J. Deep venous thrombosis in gynecological oncology: incidence and clinical symptoms study. Eur J Obstet Gynecol Reprod Biol 2009;144:173–6.
Ailawadi M, Del Priore G. A comparison of thromboembolic prophylaxis in gynecologic oncology patients. Int J Gynecol Cancer 2001;11:354–8.
Stentella P, Frega A, Cipriano L, Spera G, Palazzetti PL, Pachi A. Prevention of thromboembolic complications in women undergoing gynecologic surgery. Clin Exp Obstet Gynecol 1997;24:58–60.
Ritch JM, Kim JH, Lewin SN, Burke WM, Sun X, Herzog TJ, et al.. Venous thromboembolism and use of prophylaxis among women undergoing laparoscopic hysterectomy. Obstet Gynecol 2011;117:1367–74.
Bergqvist D, Agnelli G, Cohen AT, Eldor A, Nilsson PE, Le Moigne-Amrani A, et al.. Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. N Engl J Med 2002;346:975–80.
